Affinity Bio

  • Clinical Research Organisation

Affinity is a privately-owned biotechnology company based in Melbourne, Australia.

Founded by biotechnology entrepreneurs Ben Kiefel and Matt Beasley in 2009, Affinity started to build and develop the world’s fastest antibody discovery platform.

Affinity’s resulting technology, Retained DisplayTM (ReD), has since been tested in campaigns against some of the most difficult diagnostic and lab reagent targets the team could find.

CONTACT DETAILS

Name:
Pete Smith

Website:
https://affinity.bio

Email:
info@affinity.bio

Phone:
(03) 9763 5445

Update This Listing

Update Your Listing

Any details submitted below will be reviewed and confirmed by email before the listing is updated.

close

Stay up-to-date

Receive helpful and relevant information about conducting or supporting clinical trials in Victoria.